Global Malaria Rapid Diagnostic Tests (RDTS) Market By Product Type (Detect Only One Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)

                                          
Report updated on 11th September, 2021: Global Malaria Rapid Diagnostic Tests (RDTS) Market By Product Type (Detect Only One Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2030 (Includes Business Impact of COVID-19)
Trusted Business Insights has published a comprehensive market research report on, Global Malaria Rapid Diagnostic Tests (RDTS) Market by Product Type (Detect only one Species and Detect Multiple Species), By End Users (Hospital, Clinic and Others), and by Region -Global Forecast to 2030, which offers a holistic view of global malaria rapid diagnostic tests (RDTS) market through systematic segmentation that covers every aspect of the target market.

Global malaria rapid diagnostic tests (RDTS) market is projected to be US$ 291.03 Mn in 2020 to reach US$ 454.82 Mn by 2030 at a CAGR of 4.6%.

Malaria is predominant in tropical countries because temperature conditions in these regions are suitable for the growth of mosquitos. Malaria Rapid Diagnostic Tests (RDTS) is used to detect the presence of malaria antigen in the blood. RDTs are very easy to use, and no skilled professionals are required to conduct this test. One can conduct this test on his own from where they are. Use of Malaria Rapid Diagnostic Tests (RDTS) is becoming popular especially in rural areas because of its user-friendliness, lack of skilled technicians as well as microscopes in rural areas. Also, the result time of Malaria Rapid Diagnostic Tests (RDTS) is just about 15 to 20 minutes which is quite impressive taking into account its price and availability in the market. No infrastructure is required to carry out rapid diagnostic tests hence reduction in costs which facilitates the market growth. Malaria Rapid Diagnostic Tests (RDTS) is considered as an alternative to conventional tests conducted in clinics or pathology labs. Malaria RDTs are comparatively inexpensive and still, its results are excellent. Due to the competitive environment, the prices are declining which is expected to boost malaria rapid diagnostic tests market further. Malaria RDT evaluation program initiated by WHO and Foundation for Innovative New Diagnostics (FIND) to make pre-purchase performance evaluation and pre-distribution quality control makes the process more transparent. Healthcare professionals are increasingly giving importance to WHO compliant RDT products which in turn increases the quality of RDTs offered by manufacturers which are predicted to assist in the market progress.

These rapid diagnostic tests are particularly useful in rural areas where access to hospitals, labs, trained technicians as well as equipment such as microscope to diagnose Malaria, is somewhat limited which is predicted to drive the RDTs market forward.


Global Malaria Rapid Diagnostic Tests (RDTS) Market Revenue (US$ Mn), 2021 to 2030


However, Slow process of prequalification by the World Health Organization of RDTs could affect the growth of Malaria Rapid Diagnostic Tests (RDTS) Market. Nonetheless, the Global Fund as well as Government initiatives such as United States Presidents Malaria Initiative (PMI) etc. are investing in preventing and curing Malaria which is expected to widen the rapid diagnostic tests market scope.

Global Malaria Rapid Diagnostic Tests (RDTS) market is segmented on the basis of product type, end-user and region. On the basis of product type, the market is segmented into Detect only one Species and Detect Multiple Species. The Detect, only one Species segment, accounts for the majority share and is expected to register the highest growth over the forecast period, followed by Detect Multiple Species segment. On the basis of end user, the market is segmented into Hospital, Clinic and Others. The hospital segment accounts for a majority share in the global Malaria Rapid Diagnostic Tests (RDTS) market.


Global Malaria Rapid Diagnostic Tests (RDTS) Market by End User, 2018


On the basis of region, the market is segmented into Africa, APAC, ROW. Africa accounts for the majority share in the global Malaria Rapid Diagnostic Tests (RDTS) market, as rapid diagnostic tests are particularly useful in rural areas where access to hospitals, labs, trained technicians as well as equipment such as microscope to diagnose Malaria, is somewhat limited which is predicted to drive the RDTs market forward. APAC is expected to register the highest growth rate over the forecast period.

The research report on the global Malaria Rapid Diagnostic Tests (RDTS) market includes profiles of some of the major companies such as Abbott Laboratories (Alere Inc.)., Access Bio, Inc., Bio-Rad Laboratories, Inc., Access Bio Inc., Linde Plc and BioMerieux, Inc.



Below are the active patents related to Malaria Rapid Diagnostic Tests (RDTS) Market.


Portable rapid diagnostic test reader

Abstract

A portable rapid diagnostic test reader system includes a mobile phone having a camera and one or more processors contained within the mobile phone and a modular housing configured to mount to the mobile phone. The modular housing including a receptacle configured to receive a sample tray holding a rapid diagnostic test. At least one illumination source is disposed in the modular housing and located on one side of the rapid diagnostic test. An optical demagnifier is disposed in the modular housing interposed between the rapid diagnostic test and the mobile phone camera.

Application filed Date: 2012-05-31

Application Granted Date: 2014-12-23

Current Assignee: University of California

Key Market Segments:

By Type

  
Detect only one Species
  
Detect Multiple Species

By Application

  
Hospital
Clinic
  
Others


Key Market Players included in the report:


  
Abbott Laboratories (Alere Inc.)
  
Access Bio Inc.
  
Adaltis.
  
Alere Inc
  
Bio-Rad Laboratories Inc.
  
Linde Plc and BioMerieux Inc
  
Premier Medical Corporation


Below are the key development related to Malaria Rapid Diagnostic Tests (RDTS) Market in 2020 and 2021.


March 2021: One-Minute Malaria Test Detects Significantly More P. vivax Than Current Rapid Tests in Clinical Study Published in Malaria Journal. Gazelle from Hemex Health, the First Approved Hemozoin Detector, Holds Promise for Affordable, Easy-to-Use, Accurate Screening for P. vivax Malaria. Results of a clinical study conducted by researchers in Manaus, Brazil, show that the Gazelle® Malaria test outperformed Rapid Diagnostic Tests (RDTs) and was nearly as accurate as more expensive and time-consuming expert microscopy in detecting Plasmodium vivax (P. vivax) malaria. The data was published Friday, March 12 in the Malaria Journal. The double-blind study was based on 300 participants who sought care from FundacAo de Medicina Tropical Doutor Heitor Vieira Dourado (FMT-HVD), located in Manaus, an area in the Western Brazilian Amazon, heavily endemic for P. vivax. P. vivax is the second most prevalent malaria species infecting humans and is widespread among many countries seeking to eliminate malaria. Although considered less deadly than P. falciparum (the most common species), P. vivax infections can result in serious illness and mortality. Additionally, P. vivax presents a special challenge for diagnostics due to its typically low levels of parasitemia. Current RDTs miss many P. vivax infections, thus light microscopy, which is time-consuming and requires skilled technicians, is the current best option for many regions of the world. Researchers at FMT-HVD noted that the Gazelle Malaria Test’s use of hemozoin, a highly specific biomarker present in all species of malaria, shows promise for detecting low parasitemia P. vivax infections. When compared to optical microscopy in this study, the sensitivity and specificity of the Gazelle test were 96.2% and 100% respectively, whereas for RDTs they were 83.9% and 100%. This equates to RDTs missing 16 cases of P. vivax infection per 100 people, and Gazelle missing only 4. Source

Jun 29 2021: Rapid test kit for malaria delivers results in 30 minutes. A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a test kit for malaria that delivers results in 30 minutes. The kit could facilitate the diagnosis of malaria in the field, as the equipment needed is anticipated to be lightweight, easy-to-use, and able to detect the disease in its early stages. Source